Compare BioNano Genomics Inc (BNGO) vs State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF (FLRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.20M), while State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF trades at $30.8. The key difference: State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | FLRN | |
|---|---|---|
Market Cap | $13.20M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.92 | $30.86 |
52-Week Low | $1.09 | $30.65 |
Enterprise Value | $15.81M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
FLRN (SPDR Bloomberg Investment Grade Floating Rate ETF) trades at $30.80 with no recent price movement. The technical outlook is bearish with moving averages signaling caution, though RSI levels suggest potential oversold conditions. Recent institutional buying by Farther Finance Advisors and BCS Wealth Management indicates professional interest. The fund focuses on floating-rate investment grade bonds, positioning it as a potential hedge in the current rising rate environment.
FLRN offers exposure to floating-rate debt securities that may outperform in a rising rate environment. The fund's structure provides inflation protection benefits, but faces headwinds from potential credit quality deterioration and market volatility. Current dividend payments of $0.11 per share provide income support, though the bearish technical signals warrant careful monitoring of market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF
FLRN invests in U.S. dollar-denominated investment-grade floating rate notes with maturities under five years. It provides exposure to corporate and supranational debt whose interest payments adjust with market rates, helping to mitigate interest rate risk.
Read more on FLRN →
